<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01711996</url>
  </required_header>
  <id_info>
    <org_study_id>4-2012-0421</org_study_id>
    <nct_id>NCT01711996</nct_id>
  </id_info>
  <brief_title>The Correlation Between Renal Injury and Biomarkers in Pediatric Ureteropelvic Junction Obstruction Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Urinary Neutrophil gelatinase associated lipocalin (NGAL) has been recently reported to be&#xD;
      related with the degree of hydronephrosis in pediatric ureteropelvic junction obstruction&#xD;
      (UPJO) patients. We are trying to analyze whether it is related with the grade of renal&#xD;
      injury in UPJO patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Difficulty in purchasing reagents and receiving consent from the subject&#xD;
  </why_stopped>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The level of urinary NGAL and the degree of renal injury</measure>
    <time_frame>6 month after operation</time_frame>
    <description>Analysis of correlation between the level of urinary NGAL and the degree of renal injury</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Ureteropelvic Junction Obstruction</condition>
  <arm_group>
    <arm_group_label>UPJO</arm_group_label>
    <description>0-3 year old hydronephrosis patients without ureter dilatation who undergo pyeloplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydronephrosis</arm_group_label>
    <description>0-3 year old hydronephrosis patients without ureter dilatation who does not meet the indication of pyeloplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal</arm_group_label>
    <description>0-3 year old children without hydronephrosis</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Group 1: 20 patients with UPJO undergo pyeloplasty Group 2: 20 patients with hydronephrosis&#xD;
        who does not meet the indication of pyeloplasty Group 3: 20 normal control&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        &lt;Group 1&gt;&#xD;
&#xD;
          1. 0-3 year old patients with SFU grade 2 or more hydronephrosis without ureteral&#xD;
             dilatation&#xD;
&#xD;
          2. needs pyeloplasty due to differential renal function (DRF)&lt;40%, decreased DRF by more&#xD;
             than 5%, development of urinary tract infection, development of urinary stone, and&#xD;
             development of pain related with UPJO &lt;Group 2&gt;&#xD;
&#xD;
        1. 0-3 year old patients with SFU grade 3 or 4 hydronephrosis without ureteral dilatation&#xD;
        2. doesn't meet the above criteria for the indication of pyeloplasty &lt;Group 3&gt;&#xD;
&#xD;
        1. 0-3 year old children without any abnormality of urinary tract&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        &lt;Group 1&gt;&#xD;
&#xD;
          1. patients with contralateral disease affecting DRF&#xD;
&#xD;
          2. history of previous urinary tract surgery&#xD;
&#xD;
          3. follow up loss before diuretic renogram performed at 6-12 months from operation &lt;Group&#xD;
             2, 3&gt;&#xD;
&#xD;
        1. patients with contralateral disease affecting DRF 2. history of previous urinary tract&#xD;
        surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Urology, Urological Science Institute, Yonsei University, Colleage of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>October 17, 2012</study_first_submitted>
  <study_first_submitted_qc>October 22, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2012</study_first_posted>
  <last_update_submitted>May 3, 2021</last_update_submitted>
  <last_update_submitted_qc>May 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hydronephrosis</keyword>
  <keyword>biopsy</keyword>
  <keyword>biomarker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydronephrosis</mesh_term>
    <mesh_term>Ureteral Obstruction</mesh_term>
    <mesh_term>Multicystic Dysplastic Kidney</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

